Krystyna Prochaska

Prof. Dr. Krystyna Prochaska

orcid

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in Advances in Colloid and Interface Science
Verified
Journal Article
Closed access
KPKrystyna Prochaska
Krystyna Prochaska

14 September 2021 in Membranes
Verified
Journal Article
Open access
PDF file
MRMonika Rojewska
Monika Rojewska
Wojciech SmułekWojciech Smułek
Wojciech Smułek
Ewa KaczorekEwa Kaczorek
Ewa Kaczorek
KPKrystyna Prochaska
Krystyna Prochaska
The amounts of antibiotics of anthropogenic origin released and accumulated in the environment are known to have a negative impact on local communities of microorganisms, which leads to disturbances in the course of the biodegradation process and to growing antimicrobial resistance. This mini-review covers up-to-date information regarding problems related to the omnipresence of antibiotics and their consequences for the world of bacteria. In order to understand the interaction of antibiotics with bacterial membranes, it is necessary to explain their interaction mechanism at the molecular level. Such molecular-level interactions can be probed with Langmuir monolayers representing the cell membrane. This mini-review describes monolayer experiments undertaken to investigate the impact of selected antibiotics on components of biomembranes, with particular emphasis on the role and content of individual phospholipids and lipopolysaccharides (LPS). It is shown that the Langmuir technique may provide information about the interactions between antibiotics and lipids at the mixed film surface (π–A isotherm) and about the penetration of the active substances into the phospholipid monolayer model membranes (relaxation of the monolayer). Effects induced by antibiotics on the bacterial membrane may be correlated with their bactericidal activity, which may be vital for the selection of appropriate bacterial consortia that would ensure a high degradation efficiency of pharmaceuticals in the environment.

1 September 2014 in Bioresource Technology
Verified
Journal Article
Closed access
KPKrystyna Prochaska
Krystyna Prochaska
Katarzyna StaszakKatarzyna Staszak
Katarzyna Staszak
MWMarta Woźniak-Budych
Marta Woźniak-Budych
MRMagdalena Regel-Rosocka
Magdalena Regel-Rosocka
MAMichalina Adamczak
Michalina Adamczak
JSJacek Staniewski
Jacek Staniewski


1 September 2017 in Carbohydrate Polymers
Verified
Journal Article
Closed access
MRMonika Rojewska
Monika Rojewska
ABAleksandra Bartkowiak
Aleksandra Bartkowiak
Beata StrzemieckaBeata Strzemiecka
Beata Strzemiecka
AJA. Jamrozik
A. Jamrozik
Adam VoelkelAdam Voelkel
Adam Voelkel
KPKrystyna Prochaska
Krystyna Prochaska

1 December 2018 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
ABAleksandra Bartkowiak
Aleksandra Bartkowiak
MRMonika Rojewska
Monika Rojewska
KHK. Hyla
K. Hyla
Joanna ZembrzuskaJoanna Zembrzuska
Joanna Zembrzuska
KPKrystyna Prochaska
Krystyna Prochaska